The usefulness of skin tests to prove drug hypersensitivity.
about
Modified oral metronidazole desensitization protocol.Amoxicillin rash in patients with infectious mononucleosis: evidence of true drug sensitizationIdiosyncratic adverse reactions to antiepileptic drugs.Anticonvulsant hypersensitivity syndrome: implications for pharmaceutical care.Patch testing in non-immediate drug eruptions.Immunological aspects of nonimmediate reactions to beta-lactam antibiotics.Patch testing in fixed drug eruptions--a 20-year review.Allopurinol hypersensitivity: a systematic review of all published cases, 1950-2012.Evaluation of antibiotic allergy: the role of skin tests and drug challenges.Cellular in vitro diagnosis of adverse drug reactionsPatch testing in non-immediate cutaneous adverse drug reactions: value of extemporaneous patch tests.Non-immediate Cutaneous Reactions to Beta-Lactams: Approach to Diagnosis.Patch testing - a valuable tool for investigating non-immediate cutaneous adverse drug reactions to antibiotics.Immunologic evaluation of drug allergy.Nevirapine patch testing in Thai human immunodeficiency virus infected patients with nevirapine drug hypersensitivity.Patch testing and sensitization to multiple drugs.A patch testing and cross-sensitivity study of carbamazepine-induced severe cutaneous adverse drug reactions.Non-irritant concentrations and amounts of active ingredient in drug patch tests.Management of allergy to penicillins and other beta-lactams.Long-term reproducibility of positive patch test reactions in patients with non-immediate cutaneous adverse drug reactions to antibiotics.[Diagnostics of drug hypersensitivity reactions].Association between HLA gene polymorphism and cutaneous adverse reactions caused by antiepileptic drugs.Ivermectin-induced fixed drug eruption in an elderly Cameroonian: a case reportMechanisms in cutaneous drug hypersensitivity reactions
P2860
Q34013709-0FFD74F5-85A2-4D96-8685-1057BCD835FBQ35184919-C4F0DAEC-4D0E-40DB-B63D-ACD70BB6842EQ36770454-1C9A40F9-6410-41A5-885E-04B93DF23B8BQ36952002-B974DC25-2489-4774-9220-BD78C30B5E2BQ37762860-B37581F1-5CF7-41E5-AF52-C6EE18B11F0BQ37786631-A8B85275-E6BD-46ED-AC87-D8A91AAE8A4AQ37894119-8AB2AAB3-8232-4DD6-89C7-62D61C6758EDQ38123116-1DCA2E05-5735-412C-ACC0-FEE503819A22Q38241731-4E0D1D7D-1F2F-4B51-92DF-DCBAD5E3C24AQ38539744-65B94186-8508-428E-8C81-42F6DA3196EAQ38668592-E8798B92-8FEF-4D93-BD1C-6CE19269DC80Q39223693-83E4B0BD-CDC0-4ABE-9A1F-E200FAB9FE8AQ39539642-6EF6F70D-8064-44CA-A0EC-0A6587122F0CQ39558242-8A789A69-F566-4244-BC9D-B7E661A36431Q40092748-A79FBB3B-B54A-43A7-9B66-E30C396BE5BAQ43720821-E99EC5A8-A8B7-4721-8700-735893E1878DQ44949302-97676D4B-F777-4FF0-91AF-51927F0EE2C2Q45841855-CB716560-C2C3-4D69-9F9D-4D78225E6FA5Q50969804-F0267931-A8B5-4032-9E36-1CD1D5BA8D67Q51032254-510E93B5-9AAD-4919-A1CC-C6E6DC1D0419Q53616847-2E359010-6B35-494A-94DD-1D874328E369Q54094996-41AF6554-6E84-40D6-B881-B77C9053F8FCQ58752562-25F9AF74-1158-4365-8647-CA72B26003BFQ59281741-50F2340A-A6FF-405D-BF1C-6DB8E5C81D6A
P2860
The usefulness of skin tests to prove drug hypersensitivity.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
The usefulness of skin tests to prove drug hypersensitivity.
@en
The usefulness of skin tests to prove drug hypersensitivity.
@nl
type
label
The usefulness of skin tests to prove drug hypersensitivity.
@en
The usefulness of skin tests to prove drug hypersensitivity.
@nl
prefLabel
The usefulness of skin tests to prove drug hypersensitivity.
@en
The usefulness of skin tests to prove drug hypersensitivity.
@nl
P2860
P1476
The usefulness of skin tests to prove drug hypersensitivity.
@en
P2093
Kortekangas-Savolainen O
Lammintausta K
P2860
P304
P356
10.1111/J.1365-2133.2005.06429.X
P407
P577
2005-05-01T00:00:00Z